FDA.reportPublic FDA data

24 HR lorazepam 2 MG Extended Release Oral Capsule [Loreev]

RxCUI
2569575
RxNorm name
24 HR lorazepam 2 MG Extended Release Oral Capsule [Loreev]
Display name
24 HR lorazepam 2 MG Extended Release Oral Capsule [Loreev]
Full name
24 HR lorazepam 2 MG Extended Release Oral Capsule [Loreev]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
227734c1-bf01-9607-73ea-5a1f38a89bd9Loreev XR 2 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR lorazepam 2 MG Extended Release Oral Capsule [Loreev] [SBD] · 24 HR Loreev XR 2 MG Extended Release Oral Capsule [SY] · Loreev XR 2 MG 24 HR Extended Release Oral Capsule [SY]45These highlights do not include all the information needed to use LOREEV XR safely and effectively. See full prescribing information for LOREEV XR. LOREEV XR (lorazepam) extended-release capsules, for oral use, CIV Initial U.S. Approval: 197720251008